Huadong Medicine Co., Ltd (SHE:000963)
China · Delayed Price · Currency is CNY 29.39
-0.74 (-2.46%)
May 20, 2026, 11:54 AM CST
Huadong Medicine Market Cap
Huadong Medicine has a market cap or net worth of 52.84 billion as of May 19, 2026. Its market cap has decreased by -18.01% in one year.
Market Cap
52.84B
Enterprise Value
51.62B
Revenue
44.06B
Ranking
n/a
PE Ratio
15.09
Stock Price
29.39
Market Cap Chart
Since January 2, 2001, Huadong Medicine's market cap has increased from 4.21B to 52.84B, an increase of 1,154.99%. That is a compound annual growth rate of 10.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 52.84B | -23.45% |
| Dec 31, 2025 | 69.03B | 14.00% |
| Dec 31, 2024 | 60.55B | -16.55% |
| Dec 29, 2023 | 72.56B | -11.60% |
| Dec 30, 2022 | 82.09B | 16.70% |
| Dec 31, 2021 | 70.34B | 51.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sichuan Biokin Pharmaceutical | 106.11B |
| Zhejiang NHU Company | 101.07B |
| Yunnan Baiyao Group Co.,Ltd | 90.82B |
| Shanghai Fosun Pharmaceutical (Group) | 59.14B |
| China Resources Sanjiu Medical & Pharmaceutical | 41.49B |
| Shenzhen Salubris Pharmaceuticals | 39.30B |
| Beijing Tongrentang | 37.44B |
| Changchun High-Tech Industry (Group) | 33.80B |